attachment
attachment

This is a given case, now Read it and later I will give you what explanation I have prepared

I've read the case carefully. Here's a quick summary of what's presented:
Case Summary - Group 2
  • Patient: 24-year-old female
  • Chief complaint: Rashes over the trunk, most prominent on the back
  • History:
    • ~1 month ago: a single round rash on the chest that resolved spontaneously in ~1 week (no treatment)
    • Several days after that rash disappeared: multiple small rashes appeared on the back
    • Itching occurs only when hot/sweating
    • Applied antifungal cream for 3 weeks with no improvement
  • Image findings: Multiple scattered, oval-to-round, salmon-pink/erythematous macules/patches distributed over the back, following the skin cleavage lines (Christmas tree pattern)
Key clinical clues pointing toward a likely diagnosis:
  1. Herald patch (the initial solitary round chest lesion that self-resolved)
  2. Subsequent smaller secondary lesions on the trunk
  3. Distribution along cleavage lines
  4. Self-limiting course
  5. No response to antifungal treatment
This presentation is classic for Pityriasis Rosea.
Go ahead and share your explanation whenever you're ready - I'll review it and give you detailed feedback!

This is my presentation

Reading File
Running Command

python3 -c " import pdfplumber with pdfplumber.open('/tmp/workspace/attachments/e7ada6c6-c05c-496f-bda3-e596e84c7f40/DERMA CASE GROUP 2.pdf') as pdf: print(f'Pages: {len(pdf.pages)}') for i, page in enumerate(pdf.pages): print(f'\n--- PAGE {i+1} ---') text = page.extract_text() if text: print(text) else: print('[No text extracted - may be image-based]') "

I've read your full 25-slide presentation. Here is a thorough, honest review:

Feedback: Dermatology Case Presentation - Group 2 (Pityriasis Rosea)

Overall Impression

This is a very well-structured and clinically accurate presentation. The diagnosis is correct, the reasoning is sound, and the organization follows a logical clinical framework. Below is detailed feedback, section by section.

What Your Group Did Well

Lesion Description (Slide 6)

  • Excellent. You covered morphology, arrangement, distribution, and evolution - all four key descriptors.
  • Correctly identified the Christmas Tree pattern along Langer's cleavage lines.
  • The collarette scale detail is precise and shows good textbook knowledge.

Primary Diagnosis (Slide 7)

  • Clean, concise definition hitting all the hallmarks.
  • Correctly attributed etiology to HHV-6/HHV-7 and NOT to fungi - this directly connects to why antifungal cream failed.
  • Good epidemiology mention (age 10-35, slight female predominance, seasonal pattern).

Pathogenesis (Slide 8)

  • The flowchart is simple and accurate. For a case presentation, this level is appropriate.
  • Suggestion: You could add one extra step - mention that HHV-6/7 reactivation from a latent state (not primary infection) is the proposed mechanism. This shows deeper understanding.

Clinical Features (Slides 9-10)

  • Well-organized comparison between herald patch and secondary eruption.
  • Histopathology inclusion on Slide 10 is a nice touch, and accurately listed.

Why This Diagnosis (Slide 11)

  • Excellent checklist format. All 7 findings directly tied back to the case.
  • The "no response to antifungal" point is particularly strong - it actively rules OUT tinea and rules IN pityriasis rosea.

Differential Diagnoses (Slides 12-16)

  • This is the strongest section of your presentation.
  • You used a RULE IN / RULE OUT format for 5 differentials - this is thorough and clinically mature.
  • Tinea corporis, secondary syphilis, guttate psoriasis, nummular eczema, and pityriasis versicolor are all appropriate choices.
  • Secondary syphilis inclusion is impressive - many students forget this classic mimic.
  • For pityriasis versicolor, you correctly noted KOH would be negative for "spaghetti and meatballs" - excellent detail.

Lab Investigations (Slides 17-20)

  • Good selection: KOH prep, VDRL/RPR, skin biopsy, CBC, HIV test, and HHV PCR.
  • Each lab includes purpose, expected result, and rationale - well done.
  • Including HIV testing for atypical/severe presentations shows clinical thinking beyond the textbook.

Treatment (Slides 21-22)

  • Good coverage of the treatment ladder: reassurance → topical steroids → antihistamines → acyclovir.
  • Mechanism of action for each drug class is a nice addition.
  • You listed side effects and drug interactions - thorough.

Areas for Improvement

1. Acyclovir Dosing - Minor Accuracy Issue

You listed acyclovir 800 mg five times daily for 7 days. This is the herpes zoster dose. For pityriasis rosea, studies (including the Drago et al. trials) used 800 mg five times daily for 7 days, so this is actually consistent - good. However, be prepared for the question: "Is acyclovir actually recommended?" The evidence is limited and it is not universally endorsed in guidelines. Mention it is used in early, severe, or disseminated cases only.

2. Phototherapy Mentioned But Not Explained

Slide 22 lists "Phototherapy" at the bottom with no detail. Either:
  • Expand it (narrowband UVB, used in persistent/severe cases), or
  • Remove it to avoid an incomplete point that examiners might probe.

3. Pathogenesis Could Be Slightly Deeper

The current flowchart is correct but minimal. You could add:
  • HHV-6/7 reactivation occurs in the skin keratinocytes
  • Triggers a CD4+ T-cell mediated immune response
  • This produces the characteristic spongiosis (intercellular edema) seen on histology

4. Prognosis - Missing One Point

Slide 23 is good but you could add: "Recurrence may occur with immunosuppression" - this connects nicely to why you did the HIV test.

5. References

Only 2 references are listed (Harrison's and Fitzpatrick's). For a formal academic presentation:
  • Add the Drago et al. study on HHV-6/7 and acyclovir (this is the main evidence base for your pathogenesis and treatment claims)
  • Consider citing a review article for completeness

Summary Scorecard

SectionScoreComment
Case presentation✅ ExcellentClear and concise
Lesion description✅ ExcellentAll 4 domains covered
Primary diagnosis✅ ExcellentAccurate and complete
Pathogenesis✅ GoodCould be one step deeper
Clinical features✅ ExcellentWell-organized
Differential diagnosis✅ Excellent5 differentials, RULE IN/OUT format
Lab investigations✅ ExcellentPurpose + result + rationale
Treatment✅ GoodPhototherapy needs expansion
Prognosis✅ GoodOne point missing
References⚠️ AdequateCould add primary literature

Bottom Line

This is a high-quality case presentation that demonstrates solid clinical reasoning. The differential diagnosis section in particular is commendable. The few gaps (phototherapy, one extra pathogenesis step, references) are minor and easy to fix. You should feel confident presenting this.

Now help me understand all the slides and explain all the points from which the doctor can ask me questions

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Searching Images

pityriasis rosea herald patch Christmas tree distribution back

This image depicts a clinical dermatology photograph of the back (posterior trunk) showing multiple erythematous, oval to round plaques characteristic of pityriasis rosea. Acquired in routine outpatient photography, the lesions are salmon-pink to rose-colored, 0.5–2 cm in diameter, with fine, collarette-like scaling at the outer margin and a smooth central surface. The distribution is trunk-predominant with clustering along the spinal regions, consistent with the classic Christmas-tree pattern along skin cleavage lines. The inflammatory plaques may appear slightly raised and may coalesce in areas of friction. No confluent involvement of the face or mucosa is evident. In pityriasis rosea, the eruption often follows a herald patch, though this image focuses on the secondary eruption phase. The differential diagnosis at this stage includes tinea corporis, guttate psoriasis, secondary syphilis, and eczema; however, the sharp, circular to oval morphology, peripheral scaling, and trunk-centric distribution support pityriasis rosea. The clinical significance rests in recognizing its typical self-limited course, usually resolving within several weeks to months and requiring supportive care for itch. This image is relevant for educational demonstrations of PR skin manifestations, photographic recognition in dermatology training, and comparative studies of pityriasis rosea presentations across phototypes. Potential clinical uses include triage, patient education, and dermatologic image search for pattern recognition.

This image depicts a clinical dermatology photograph of the back (posterior trunk) showing multiple erythematous, oval to round plaques characteristic of pityriasis rosea. Acquired in routine outpatient photography, the lesions are salmon-pink to rose-colored, 0.5–2 cm in diameter, with fine, collarette-like scaling at the outer margin and a smooth central surface. The distribution is trunk-predominant with clustering along the spinal regions, consistent with the classic Christmas-tree pattern along skin cleavage lines. The inflammatory plaques may appear slightly raised and may coalesce in areas of friction. No confluent involvement of the face or mucosa is evident. In pityriasis rosea, the eruption often follows a herald patch, though this image focuses on the secondary eruption phase. The differential diagnosis at this stage includes tinea corporis, guttate psoriasis, secondary syphilis, and eczema; however, the sharp, circular to oval morphology, peripheral scaling, and trunk-centric distribution support pityriasis rosea. The clinical significance rests in recognizing its typical self-limited course, usually resolving within several weeks to months and requiring supportive care for itch. This image is relevant for educational demonstrations of PR skin manifestations, photographic recognition in dermatology training, and comparative studies of pityriasis rosea presentations across phototypes. Potential clinical uses include triage, patient education, and dermatologic image search for pattern recognition.

Clinical photograph of the back demonstrating pityriasis rosea-like eruption. High-resolution color image capturing multiple oval annular plaques with salmon-pink hue and fine collarette scaling along the trunk. The long axis of each lesion is oriented approximately parallel to the ribs, creating a pattern that follows the thoracic dermatomal distribution on the dorsal chest and flanks. Lesions are predominantly superficial, ill-defined at the periphery, with central clearing and variable sizes ranging from several millimeters to a centimeter. The overall appearance is erythematous, mildly pruritic, and arranged in a trunk-centered, zigzag or Christmas tree distribution, typical of pityriasis rosea. Differential considerations include tinea corporis, pityriasis versicolor, guttate psoriasis, and nummular eczema. Clinically, this presentation supports the diagnosis of pityriasis rosea when accompanied by a herald patch or secondary eruption; histopathology is not provided. The image is intended for education, differential diagnosis training, and radiological-free dermatology research; useful for teaching pattern recognition, dermography, and dermatoepidemiology. The photograph emphasizes trunk involvement with characteristic collarette scaling, aiding clinicians in distinguishing PR from mimickers and in counseling patients about the self-limited course (usually 6-8 weeks) and symptomatic management options. No systemic symptoms are evident; findings support a benign, self-limited cutaneous eruption in most cases for clinicians.

Clinical photograph of the back demonstrating pityriasis rosea-like eruption. High-resolution color image capturing multiple oval annular plaques with salmon-pink hue and fine collarette scaling along the trunk. The long axis of each lesion is oriented approximately parallel to the ribs, creating a pattern that follows the thoracic dermatomal distribution on the dorsal chest and flanks. Lesions are predominantly superficial, ill-defined at the periphery, with central clearing and variable sizes ranging from several millimeters to a centimeter. The overall appearance is erythematous, mildly pruritic, and arranged in a trunk-centered, zigzag or Christmas tree distribution, typical of pityriasis rosea. Differential considerations include tinea corporis, pityriasis versicolor, guttate psoriasis, and nummular eczema. Clinically, this presentation supports the diagnosis of pityriasis rosea when accompanied by a herald patch or secondary eruption; histopathology is not provided. The image is intended for education, differential diagnosis training, and radiological-free dermatology research; useful for teaching pattern recognition, dermography, and dermatoepidemiology. The photograph emphasizes trunk involvement with characteristic collarette scaling, aiding clinicians in distinguishing PR from mimickers and in counseling patients about the self-limited course (usually 6-8 weeks) and symptomatic management options. No systemic symptoms are evident; findings support a benign, self-limited cutaneous eruption in most cases for clinicians.

Clinical dermatology photograph of the upper back and posterior neck demonstrates classic pityriasis rosea with a herald patch. The main lesion is a solitary, oval, salmon‑pink plaque with fine, collarette scaling along the outer margin. The lesion size is larger than subsequent papules and appears slightly raised with less surface involvement centrally. Surrounding the trunk shows numerous smaller erythematous papules and plaques distributed in a crest-like or zigzag pattern consistent with secondary eruption along Langer's lines, sometimes described as a Christmas tree distribution on the torso. Coloration ranges from pink to coral; scaling is peripheral and secondary lesions may be pruritic. The overall clinical impression is pityriasis rosea in an early or evolving stage, with herald patch indicating onset often preceding generalized eruption by days to weeks. Differential considerations include tinea corporis and secondary syphilis, which can resemble patchy erythema and collarette scaling; correlate clinically and with serology if indicated. The image highlights typical dermatologic features such as circinate patches, mild edema, and intact epidermis without crusting or vesiculation. This presentation is self-limited, benign, and usually resolves within 6–8 weeks with symptomatic care. Reassurance and avoidance of irritants are appropriate management, with follow-up to ensure resolution. If lesions persist or patient reports systemic symptoms, consider dermoscopic evaluation and confirmatory testing as indicated. Early diagnosis guides management decisions.

Clinical dermatology photograph of the upper back and posterior neck demonstrates classic pityriasis rosea with a herald patch. The main lesion is a solitary, oval, salmon‑pink plaque with fine, collarette scaling along the outer margin. The lesion size is larger than subsequent papules and appears slightly raised with less surface involvement centrally. Surrounding the trunk shows numerous smaller erythematous papules and plaques distributed in a crest-like or zigzag pattern consistent with secondary eruption along Langer's lines, sometimes described as a Christmas tree distribution on the torso. Coloration ranges from pink to coral; scaling is peripheral and secondary lesions may be pruritic. The overall clinical impression is pityriasis rosea in an early or evolving stage, with herald patch indicating onset often preceding generalized eruption by days to weeks. Differential considerations include tinea corporis and secondary syphilis, which can resemble patchy erythema and collarette scaling; correlate clinically and with serology if indicated. The image highlights typical dermatologic features such as circinate patches, mild edema, and intact epidermis without crusting or vesiculation. This presentation is self-limited, benign, and usually resolves within 6–8 weeks with symptomatic care. Reassurance and avoidance of irritants are appropriate management, with follow-up to ensure resolution. If lesions persist or patient reports systemic symptoms, consider dermoscopic evaluation and confirmatory testing as indicated. Early diagnosis guides management decisions.

This is a high-resolution clinical photograph of the dorsal trunk showing a mildly symptomatic pityriasis rosea eruption. The image captures numerous discrete erythematous to pink papules and plaques on the back, many displaying fine overlying scale concentrated at the periphery (collarette scale). Lesions are small to medium in size (roughly 3-6 mm) and arranged diffusely across the posterior torso, without mucosal involvement. The distribution is characteristic for pityriasis rosea, with trunk predominance and a tendency to align along cleavage lines, producing a subtle christmas tree pattern in classic cases, though such configuration may be less evident in isolated back photographs. The coloration is uniform, with slight central clearing in some lesions and a flatter, smooth surface in others. No vesiculation, crusting, or purpura is evident. The image does not reveal the herald patch, which may precede or accompany the eruption. This photographic record is intended for dermatology education, differential diagnosis training, and clinical pattern recognition; it supports rapid recognition of PR versus mimickers such as tinea corporis and psoriasis. The image could be used in teaching modules, teledermatology consultations, and AI-based pattern recognition research to improve diagnostic accuracy and triage in skin-of-color presentations when available.

This is a high-resolution clinical photograph of the dorsal trunk showing a mildly symptomatic pityriasis rosea eruption. The image captures numerous discrete erythematous to pink papules and plaques on the back, many displaying fine overlying scale concentrated at the periphery (collarette scale). Lesions are small to medium in size (roughly 3-6 mm) and arranged diffusely across the posterior torso, without mucosal involvement. The distribution is characteristic for pityriasis rosea, with trunk predominance and a tendency to align along cleavage lines, producing a subtle christmas tree pattern in classic cases, though such configuration may be less evident in isolated back photographs. The coloration is uniform, with slight central clearing in some lesions and a flatter, smooth surface in others. No vesiculation, crusting, or purpura is evident. The image does not reveal the herald patch, which may precede or accompany the eruption. This photographic record is intended for dermatology education, differential diagnosis training, and clinical pattern recognition; it supports rapid recognition of PR versus mimickers such as tinea corporis and psoriasis. The image could be used in teaching modules, teledermatology consultations, and AI-based pattern recognition research to improve diagnostic accuracy and triage in skin-of-color presentations when available.

Here is your complete slide-by-slide study guide with all likely doctor questions and full answers, sourced from Fitzpatrick's Dermatology and Andrews' Diseases of the Skin.

Complete Study Guide: Pityriasis Rosea

Slide-by-Slide Breakdown + Expected Doctor Questions

Here are reference images to orient you visually before we begin:
Pityriasis rosea - Christmas tree distribution on back
Herald patch with secondary eruption along cleavage lines

SLIDE 3-4: THE CASE

Q: What is the most significant clue in this history that points to the diagnosis?
The herald patch - a single, round, self-resolving rash on the chest that disappeared in one week, BEFORE the widespread eruption appeared. This sequential pattern is pathognomonic. About 80% of PR cases have a herald patch, and it precedes the secondary eruption by approximately 2 weeks in adults.
Q: Why does itching worsen with heat and sweating?
Pityriasis rosea-related pruritus is worsened by heat and sweating because elevated skin temperature and sweat lower the itch threshold - this is also called the "hot bath sign" or thermally aggravated pruritus. This is a classic feature of PR and is different from allergic conditions where itching is constant.
Q: Why didn't the antifungal cream work?
Because pityriasis rosea is NOT a fungal infection - it is a viral exanthem, most likely caused by HHV-6/HHV-7 reactivation. Antifungal agents (like clotrimazole, miconazole) only target fungal cell membrane ergosterol - they have no activity against herpesviruses. The failure of antifungal therapy is actually a diagnostic clue that helps confirm PR and rule out tinea corporis and pityriasis versicolor.

SLIDE 6: LESION DESCRIPTION

Q: What are Langer's cleavage lines?
Langer's lines (also called lines of cleavage or tension lines) are natural orientations of collagen fibers in the dermis. On the trunk/back, they run diagonally downward and outward from the spine, like branches of a Christmas tree. In PR, the oval lesions align their long axis parallel to these lines, producing the Christmas tree pattern. This happens because the virus spreads along dermatomes and perivascular lymphatics that follow these planes.
Q: What is a collarette scale and why does it form at the margin?
A collarette scale is a ring of fine, crinkled scale that sits just inside the periphery of each lesion, with the free edge of the scale pointing inward (toward the center of the lesion). It forms because the active inflammatory process starts at the outer edge of the plaque and moves centrally. The center of the lesion heals first while the periphery is still active, lifting the dead skin inward. This is sometimes called the "hanging curtain sign" when the skin is stretched.
Q: What is the difference between the herald patch and the secondary lesions?
FeatureHerald PatchSecondary Lesions
Size2-10 cm (large)0.5-2 cm (smaller)
NumberSingleMultiple
LocationTrunk (50%), neck, extremitiesTrunk, proximal limbs
TimingAppears 1-2 weeks firstAppear after herald patch involutes
DistributionIsolatedChristmas tree pattern
Q: What does "salmon-colored" mean and why is it important?
Salmon color refers to a pink-orange hue caused by mild inflammation with superficial vascular dilation in fair skin. In darker-skinned patients, lesions may appear hyperpigmented or even hypopigmented after resolution. Recognizing this color helps distinguish PR from the silvery-white scale of psoriasis or the brown macules of pityriasis versicolor.

SLIDE 7: PRIMARY DIAGNOSIS - DEFINITION & ETIOLOGY

Q: What does "pityriasis rosea" actually mean?
The name was coined by Gibert in 1860. "Pityriasis" comes from Greek meaning scaly, and "rosea" means pink. Together: pink scales - which accurately describes the appearance of the lesions.
Q: What is the exact proposed etiology?
The most accepted theory is reactivation of HHV-6 and/or HHV-7 (human herpesviruses). These viruses are acquired in early childhood (nearly universal by age 3) and remain latent in mononuclear cells (T-lymphocytes and monocytes). Reactivation - possibly triggered by stress, fever, or immunosuppression - leads to viremia and then the skin eruption. Key evidence:
  • Watanabe et al. (2002) demonstrated active HHV-6/HHV-7 replication in skin lesion mononuclear cells
  • Drago et al. found HHV-6/7 in serum of PR patients including those who miscarried
  • HHV-7 is detected more often than HHV-6 in most series
Q: Why is PR NOT contagious if it is viral?
Because it is caused by reactivation of a latent virus that nearly everyone already carries - not a new primary infection being transmitted person to person. The virus is not being actively shed in respiratory secretions or skin contact. Clustering of cases in households/dormitories has been reported occasionally, but true horizontal transmission is not established.
Q: What drugs can cause a PR-like eruption?
This is a common "trap" question. Drug-induced PR-like rashes can be caused by: captopril, imatinib, interferon, lisinopril, adalimumab, lamotrigine, rituximab, lithium, barbiturates, gold, arsenic, and notably the BCG vaccine. Always ask about recent medications/vaccinations to exclude a drug eruption masquerading as PR.

SLIDE 8: PATHOGENESIS

Q: Walk me through the full pathogenesis of pityriasis rosea.
  1. Latent HHV-6/7 resides in skin keratinocytes and circulating CD4+ T-lymphocytes/monocytes from childhood infection
  2. A trigger (febrile illness, stress, immunosuppression) causes viral reactivation and viremia
  3. The virus seeds the skin via hematogenous spread, particularly to keratinocytes
  4. The immune system mounts a CD4+ T-cell mediated response against virally infected cells
  5. This inflammatory response causes spongiosis (intercellular edema of the epidermis) and superficial perivascular lymphocytic infiltrate in the dermis
  6. The result is the characteristic papulosquamous eruption
  7. Once viral antigen is cleared, the immune response resolves and lesions heal spontaneously within 6-8 weeks
Q: Why does the herald patch appear first and then the secondary eruption?
The herald patch represents the site of initial viral seeding - essentially the first focus where the virus reaches the skin after viremia begins. The secondary eruption represents subsequent widespread hematogenous dissemination to the entire skin surface. The 1-2 week delay corresponds to the time needed for viremia to spread broadly before the immune response contains it.

SLIDE 9-10: CLINICAL FEATURES & HISTOPATHOLOGY

Q: What percentage of patients have a herald patch?
Approximately 80% of cases have an identifiable herald patch. It is absent in about 20%, making those cases harder to diagnose. It can also appear simultaneously with the secondary eruption, or rarely be the only manifestation.
Q: What systemic symptoms can occur in PR?
Prodromal/concurrent symptoms occur in 5-69% of patients and include:
  • Fatigue and malaise
  • Headache
  • Nausea
  • Mild upper respiratory symptoms (sore throat, runny nose)
  • Arthralgias These symptoms reflect the underlying viral reactivation/viremia.
Q: What does "spongiosis" mean in histopathology?
Spongiosis is intercellular edema within the epidermis - fluid accumulates between keratinocytes, stretching the desmosomes and giving a "spongy" appearance under the microscope. It is the hallmark of eczematous/inflammatory reactions. In PR it is mild and helps distinguish it from psoriasis (which shows NO spongiosis but has Munro microabscesses).
Q: What are the histopathological features of PR and what do each indicate?
FindingWhat It Indicates
Mild spongiosisEpidermal edema from inflammation
Focal parakeratosisRetained nuclei in stratum corneum - rapid cell turnover
Mild acanthosisEpidermal thickening
Extravasated RBCsLeaky vessels - mild inflammation
Superficial perivascular lymphocytic infiltrateT-cell mediated immune response around dermal capillaries
Q: Is a skin biopsy diagnostic for PR?
No. The histological findings in PR are not specific - they can be seen in other papulosquamous diseases. Biopsy is done only if: (a) the clinical picture is atypical, (b) the eruption persists beyond 12 weeks, or (c) secondary syphilis cannot be excluded. The biopsy helps by excluding other diagnoses rather than confirming PR.

SLIDE 11: WHY THIS DIAGNOSIS

Q: What is the most important single finding that clinches the diagnosis of PR in this case?
The herald patch - the initial single round lesion on the chest that spontaneously resolved in one week before the widespread eruption appeared. This sequential history is nearly pathognomonic for PR and is not seen in any of the main differential diagnoses.
Q: What is the significance of "no response to antifungal"?
It actively rules out the two most common fungal mimics:
  • Tinea corporis - would respond to azole antifungals within 2-4 weeks
  • Pityriasis versicolor - would respond to topical antifungals Three weeks of antifungal with zero improvement strongly supports a non-fungal etiology, pointing toward PR.

SLIDE 12-16: DIFFERENTIAL DIAGNOSES

Q: How do you clinically distinguish PR from Tinea Corporis?
FeaturePRTinea Corporis
Herald patchYesNo
Lesion borderCollarette scale (inward-pointing)Raised, active, outward-pointing scaly border
Central clearingSubtlePronounced (annular)
KOH prepNegativePositive (hyphae)
DistributionChristmas tree on trunkScattered, any site
Antifungal responseNoYes
Q: Why must you always rule out secondary syphilis in a PR-like rash?
Because secondary syphilis is a great mimic and missing it has serious consequences (untreated syphilis progresses to tertiary disease including cardiovascular and neurosyphilis). Syphilis incidence is rising globally. The key distinguishing features of secondary syphilis are: palmoplantar involvement (palms and soles), mucous membrane patches, generalized lymphadenopathy, condyloma lata, and positive VDRL/RPR. PR typically spares palms/soles and has no lymphadenopathy.
Q: What is the "Auspitz sign" and which diagnosis does it belong to?
The Auspitz sign is pinpoint bleeding that occurs when scale is removed from a psoriatic plaque (due to dilated dermal capillaries extending into thinned suprapapillary epidermis). It is characteristic of psoriasis (including guttate psoriasis). It is absent in PR, which helps differentiate them.
Q: What is the "spaghetti and meatballs" appearance and which condition shows it?
This describes the KOH microscopic appearance of Pityriasis (Tinea) Versicolor - caused by Malassezia furfur. Short hyphae = "spaghetti", clusters of yeast spores = "meatballs". This appearance would be absent in PR (KOH negative), which is a key distinguishing test.
Q: What is the Wickham striae and which condition shows it?
Wickham striae are fine white lines/streaks visible on the surface of flat-topped violaceous papules of Lichen Planus. This is absent in PR. Lichen planus could occasionally be confused with the papular variant of PR.

SLIDE 17-20: LABORATORY INVESTIGATIONS

Q: What is a KOH preparation and how is it done?
Potassium hydroxide (KOH) prep is a bedside test for fungal infection:
  1. Scrape the active border of the lesion onto a glass slide
  2. Add 10-20% KOH solution + gentle heat (optional)
  3. KOH dissolves keratin/debris but leaves fungal hyphae intact
  4. View under microscopy: positive = fungal hyphae (tinea) or "spaghetti and meatballs" (tinea versicolor)
  5. In PR: expected to be NEGATIVE
Q: What is VDRL and how does it work?
VDRL (Venereal Disease Research Laboratory) is a non-treponemal screening test for syphilis. It detects reagin antibodies (anti-cardiolipin/anti-phospholipid) produced by the body in response to treponemal infection. A positive VDRL is then confirmed with a treponemal test (FTA-ABS or TPPA). In PR, VDRL is expected to be negative. False positives can occur in pregnancy, SLE, and other infections.
Q: What is the role of HIV testing in PR?
HIV testing is done because immunosuppression can cause atypical, severe, or persistent PR. In HIV patients, PR may be more widespread, have unusual morphology (vesicular, papular, purpuric), resist treatment, and last longer than 12 weeks. So if the clinical picture is atypical or severe, checking the immune status is appropriate.
Q: Why is HHV-6/7 PCR not done routinely?
Because: (a) most adults are already seropositive for HHV-6/7 from childhood infection, making serology hard to interpret; (b) distinguishing latent vs active infection by PCR requires quantitative methods; (c) PR is a clinical diagnosis and the result does not change management; (d) the test is mainly used in research settings or in transplant patients where HHV-6 reactivation has more serious implications.

SLIDE 21-22: TREATMENT

Q: What is the first-line management of PR?
The cornerstone is reassurance - telling the patient that PR is self-limiting and will resolve in 6-8 weeks (sometimes up to 12 weeks) without any specific treatment. General measures: avoid overheating, wear loose cotton clothing, use gentle soap, avoid hot showers, avoid scratching. Most patients need nothing beyond this.
Q: How do topical corticosteroids work and which ones are used in PR?
Mechanism: Topical steroids bind intracellular glucocorticoid receptors → suppress phospholipase A2 → decrease arachidonic acid → reduce prostaglandins and leukotrienes → less inflammation and pruritus. In PR, mild-to-moderate potency steroids are used (e.g., hydrocortisone 1% for face/flexures, triamcinolone 0.1% for trunk). Avoid high-potency steroids for prolonged periods - they cause skin atrophy, striae, telangiectasia, and hypopigmentation.
Q: How do antihistamines help in PR?
PR pruritus has a histamine-mediated component. H1 antihistamines block histamine at H1 receptors in skin and CNS → reduce itch sensation. Choices:
  • Cetirizine/Loratadine (non-sedating) - daytime use
  • Hydroxyzine (sedating) - useful at night because itch is often worse at night and the sedation helps sleep Dry mouth and drowsiness (with hydroxyzine) are the main side effects.
Q: What is the role of acyclovir in PR?
Acyclovir is an antiviral used in moderate-to-severe PR, preferably early in the course. Mechanism: Acyclovir is phosphorylated by viral thymidine kinase to acyclovir triphosphate → inhibits viral DNA polymerase → terminates DNA chain elongation → stops HHV-6/7 replication. Dose: 800 mg orally 5 times daily for 7 days. Evidence: Ganguly (2014) - a randomized, double-blind, placebo-controlled trial - showed acyclovir hastened resolution and reduced severity. It is NOT used routinely in mild cases.
Q: What is phototherapy and when is it used in PR?
Narrowband UVB (NB-UVB) phototherapy is used in cases of persistent or severe PR that fail to resolve within the typical timeframe. Mechanism: UVB radiation suppresses cutaneous immune responses, induces T-cell apoptosis, and reduces inflammatory cytokines in the skin. It is a second-line option for resistant/persistent cases. A study by Yalkova et al. (2004) supported UVB use in PR.
Q: What is the drug interaction concern with hydroxyzine?
Hydroxyzine potentiates CNS depression when combined with alcohol, opioids, benzodiazepines, or other sedatives. This is a pharmacodynamic interaction (additive CNS depression), not a pharmacokinetic one. It can also cause QT prolongation at high doses.

SLIDE 23: PROGNOSIS

Q: What is the recurrence rate of PR?
Recurrence is uncommon - 1.8% to 3.7% in most studies (Fitzpatrick's reports <3%). When recurrence happens, the second episode usually lacks a herald patch, involves fewer lesions, and resolves faster than the first.
Q: What happens to darker-skinned patients after PR resolves?
Darker-skinned patients are more prone to post-inflammatory hyperpigmentation (PIH) - the healed skin appears darker than normal for weeks to months. This is because melanocytes respond to inflammation by producing excess melanin. PIH is not permanent and fades over time. No permanent scarring occurs in PR.
Q: Can PR affect pregnancy? Why is this important?
Yes. PR in early pregnancy (first 15 weeks) is associated with: premature delivery, neonatal hypotonia, and fetal loss (miscarriage). Drago et al. demonstrated HHV-6/7 in the serum of pregnant women with PR who miscarried. This is why - while PR is benign in most people - it needs to be taken seriously in a pregnant patient, and obstetric monitoring is warranted.

BONUS: Curveball Questions the Doctor May Ask

Q: What would you tell this patient when she asks "Will this come back?"
"This condition almost always resolves completely within 6-8 weeks and rarely comes back. Less than 3% of people experience a recurrence. You may notice some darkening of the skin where the rashes were, but that will fade over time and leave no scars."
Q: What if this patient was pregnant?
PR in the first 15 weeks of pregnancy is associated with miscarriage and neonatal complications due to HHV-6/7 viremia crossing the placenta. Management would include OB-GYN referral and closer monitoring. Acyclovir use in pregnancy requires careful risk-benefit assessment.
Q: What if the rash persists beyond 12 weeks?
A rash persisting beyond 12 weeks is called the persistent form of PR. At that point, you should: (a) reconsider the diagnosis - is this actually secondary syphilis, parapsoriasis, or mycosis fungoides? (b) reassess for underlying immunosuppression (HIV); (c) perform skin biopsy for histopathology; (d) consider NB-UVB phototherapy or a short course of acyclovir.
Q: What is "inverse PR" or atypical distribution?
Some patients have atypical PR involving the face, scalp, axillae, groin, or sparing the trunk entirely (inverse pattern). This is more common in children and patients with darker skin. The Christmas tree pattern may be absent. These atypical cases are harder to diagnose and require broader differential workup.

This covers every point in your presentation at examination depth. The most likely areas a doctor will probe are: the herald patch mechanism, the pathogenesis (HHV-6/7 reactivation), the Langer's lines/Christmas tree pattern, why antifungal failed, differentiating from secondary syphilis, and the acyclovir rationale. Know those cold and you will handle any question confidently.
This is a shared conversation. Sign in to Orris to start your own chat.